Not finding it? Sign in to also search OpenAlex live.
-
Limbic Alzheimer’s co-pathology in multiple system atrophy is associated with cognitive impairment and diagnostic inaccuracy2025 Acta Neuropathologica article Medicine Parkinson's Disease Mechanisms and Treatments Open access
Janna van Wetering, Natasja A. C. Deshayes, Inês Fernandes, Dagmar H. Hepp, Henk W. Berendse, Laura E. Jonkman, +2 more
2citations -
Cytotoxic T cell recognition of α-synuclein drives pathogenic immune responses in multiple system atrophy2026 Proceedings of the National Academy of Sciences article Medicine Parkinson's Disease Mechanisms and Treatments Open access
Jae‐Seung Moon, Salvinaz Islam Moutusy, Mengrui Zhang, Alain Ndayisaba, Diego Rodriguez, Daniel N. El Kodsi, +12 more
2citations -
Tolerability and efficacy of full-body head-up tilt sleeping in Parkinson’s disease and multiple system atrophy2026 npj Parkinson s Disease article Medicine Cardiovascular Syncope and Autonomic Disorders Open access
Amber H. van der Stam, Nienke M. de Vries, Sharon Shmuely, Susanne Tamara de Bot, Jurgen A.H.R. Claassen, Alessandra Fanciulli, +8 more
0citations -
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT2024 Bone Marrow Transplantation article Medicine Multiple Myeloma Research and Treatments Open access
Meral Beksaç, Diderik-Jan Eikema, Linda Köster, Cyrille Hulin, Xavier Poiré, Rose‐Marie Hamladji, +19 more
1citations -
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksaç, Dirk‐Jan Eikema, Linda Köster, Cyrille Hulin, Xavier Poiré, Rose‐Marie Hamladji, +19 more
0citations -
Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
Hartmut Goldschmidt, Eva Nievergall, Roland R. Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, +25 more
33citations -
A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party
Meral Beksaç, Simona Iacobelli, Linda Köster, Didier Blaise, Jan J. Cornelissen, Peter Pal Remenyi, +19 more
4citations -
Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Analysis of Part 1 of an Open-Label, Multicenter, Randomized, Phase 3 Trial (GMMG-HD7)
Hartmut Goldschmidt, Uta Bertsch, Ema Požek, Axel Benner, Roland R. Fenk, Britta Besemer, +26 more
1citations -
Assessing clinical decision support system tools in precision oncology: piloting ring testing2026 ESMO Real World Data and Digital Oncology article Medicine Artificial Intelligence in Healthcare and Education Open access
Vigdis Nygaard, S. Zhao, D. Tamborero, Richard Rosenquist, Albrecht Stenzinger, Paul Roepman, +15 more
0citations -
Donor Heart Allocation Systems in Europe A Scientific Statement of the Heart Failure Association of the ESC2025 European Journal of Heart Failure review Medicine Transplantation: Methods and Outcomes Open access
Hoong Sern Lim, Kevin Damman, Guillaume Baudry, Maja Čikeš, Stamatis N. Adamopoulos, Tuvia Ben Gal, +10 more
15citations -
Percentile‐based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels2021 Journal of Cachexia Sarcopenia and Muscle article Medicine Nutrition and Health in Aging Open access
Jan Peter Marquardt, Eric J. Roeland, Emily E. Van Seventer, Till Dominik Best, Nora Horick, Ryan David Nipp, +1 more
34citations -
Neuroinflammatory Cerebrospinal Fluid Biomarkers as Predictors of Disease Progression in Multiple Sclerosis: Evidence from the Netherlands2026 Ibn Sina Journal of Medical Science Health & Pharmacy article Medicine Multiple Sclerosis Research Studies Open access
B. J. Asten, A. M. Gelder, I. N Creemers, C. der Hem, J. van Ruijter, Christina Taylor, +1 more
0citations -
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma2023 Drug Delivery and Translational Research article Medicine Multiple Myeloma Research and Treatments Open access
Josbert M. Metselaar, Twan Lammers, Amelie Boquoi, Roland R. Fenk, Fabio J. Testaquadra, Mirle Schemionek, +4 more
13citations -
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study2020 The Lancet Haematology article Medicine Multiple Myeloma Research and Treatments Open access cited by 2 patents
Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Athanasios Dimopoulos, +54 more
384citations -
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, +46 more
182citations -
The Use of Nitrosative Stress Molecules as Potential Diagnostic Biomarkers in Multiple Sclerosis2024 International Journal of Molecular Sciences article Medicine Multiple Sclerosis Research Studies Open access
Saskia Jania Räuber, Moritz Förster, Julia Schüller, Alice Willison, Kristin S. Golombeck, Christina B. Schroeter, +21 more
5citations -
Outcomes of multiple myeloma (MM) patients with del 17p as a sole high risk cytogenetic abnormality who underwent either single or tandem upfront autologous stem cell transplant approaches in EBMT centres between 2016 and 2022
Conal Houstoun, Patrick John Hayden, Dirk‐Jan Eikema, Linda Köster, Sandra Sauer, Annoek E. C. Broers, +19 more
0citations -
Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide and Dexamethasone (VRd) Versus Alone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma or for Whom Transplant Is Not Planned As Initial Therapy: Analysis of Minimal Residual Disease in the Cepheus Trial
Sonja Zweegman, Thierry T.F. Facon, Vânia Hungria, Nizar Jacques Bahlis, Christopher Paul Venner, Marc Justin Braunstein, +22 more
13citations